Unity Biotechnology (STU:9U90) EV-to-EBIT : -0.32 (As of May. 22, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Unity Biotechnology's Enterprise Value is €9.93 Mil. Unity Biotechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-30.95 Mil. Therefore, Unity Biotechnology's EV-to-EBIT for today is -0.32.

The historical rank and industry rank for Unity Biotechnology's EV-to-EBIT or its related term are showing as below:

STU:9U90' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.62 Med: -0.44 Max: 1.7
Current: -0.32

During the past 8 years, the highest EV-to-EBIT of Unity Biotechnology was 1.70. The lowest was -7.62. And the median was -0.44.

STU:9U90's EV-to-EBIT is ranked worse than
100% of 423 companies
in the Biotechnology industry
Industry Median: 10.05 vs STU:9U90: -0.32

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Unity Biotechnology's Enterprise Value for the quarter that ended in Mar. 2024 was €11.80 Mil. Unity Biotechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-30.95 Mil. Unity Biotechnology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -262.32%.

Unity Biotechnology EV-to-EBIT Historical Data

The historical data trend for Unity Biotechnology's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology EV-to-EBIT Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-2.59

-2.65

-1.04

0.13

-0.43

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															0.49	-0.43	-0.48	-0.43	-0.41

Competitive Comparison of Unity Biotechnology's EV-to-EBIT

For the Biotechnology subindustry, Unity Biotechnology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unity Biotechnology's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Unity Biotechnology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Unity Biotechnology's EV-to-EBIT falls into.

Unity Biotechnology EV-to-EBIT Calculation

Unity Biotechnology's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	9.933	/	-30.947
	=	-0.32

Unity Biotechnology's current Enterprise Value is €9.93 Mil.
Unity Biotechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-30.95 Mil.

Unity Biotechnology (STU:9U90) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Unity Biotechnology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-30.947	/	11.797503
	=	-262.32 %

Unity Biotechnology's Enterprise Value for the quarter that ended in Mar. 2024 was €11.80 Mil.
Unity Biotechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-30.95 Mil.

Unity Biotechnology EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines